Echocardiography and monitoring patients receiving dopamine agonist therapy for hyperprolactinaemia: A joint position statement of the British Society of Echocardiography, the British Heart Valve Society and the Society for Endocrinology-Reference-Cited by-同舟云学术

Echocardiography and monitoring patients receiving dopamine agonist therapy for hyperprolactinaemia: A joint position statement of the British Society of Echocardiography, the British Heart Valve Society and the Society for Endocrinology

Published:2019-02-28 Issue:5 Volume:90 Page:662-669
ISSN:0300-0664
Container-title:Clinical Endocrinology
language:en
Short-container-title:Clin Endocrinol

Author:

Steeds Richard¹²^ORCID,Stiles Craig³,Sharma Vishal⁴,Chambers John⁵,Lloyd Guy⁶,Drake William⁷

Affiliation:

1. Institute of Cardiovascular Sciences University of Birmingham Birmingham UK

2. Department of Cardiology University Hospitals Birmingham NHS Foundation Trust Birmingham UK

3. Department of Endocrinology Saint Bartholomew's Hospital London UK

4. Royal Liverpool and Broadgreen University Hospital Liverpool UK

5. Cardiothoracic Centre Guy’s and St Thomas’ Hospitals London UK

6. Cardiology Department Saint Bartholomew's Hospital London UK

7. Department of Endocrinology Bartholomew’s Hospital London UK

Publisher

Wiley

Subject

Endocrinology, Diabetes and Metabolism,Endocrinology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/cen.13940

Reference39 articles.

1. Dopamine Agonists and the Risk of Cardiac-Valve Regurgitation

2. Valvular Heart Disease and the Use of Dopamine Agonists for Parkinson's Disease

3. Treatment of Parkinson's disease with pergolide and relation to restrictive valvular heart disease

4. Guidelines of the Pituitary Society for the diagnosis and management of prolactinomas

5. A Follow-Up Study of the Prevalence of Valvular Heart Abnormalities in Hyperprolactinemic Patients Treated With Cabergoline

Cited by 20 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Reply to ‘Tumour fibrosis in dopamine agonist-exposed prolactinomas is a diminishing concern’;Nature Reviews Endocrinology;2024-03-20

2. Consensus guideline for the diagnosis and management of pituitary adenomas in childhood and adolescence: Part 2, specific diseases;Nature Reviews Endocrinology;2024-02-09

3. Prolactinomas: Clinical manifestations and therapy;Reference Module in Biomedical Sciences;2024

4. Cabergoline as a Preventive Migraine Treatment: An Investigator-Initiated Randomized Controlled Trial;2023-12-29

5. Italian Guidelines for the Management of Prolactinomas;Endocrine, Metabolic & Immune Disorders - Drug Targets;2023-10